The technology developed is a novel fluorescent biocompatible probe to detect oxidative damage in live cells and tissues in as little as 5 minutes.
The probe outperforms various commercially available toxicity and reactive oxygen species assays, demonstrating superior sensitivity and signal-to-noise ratios.
• Live cell and tissue compatible
• Cellular damage can be detected at lower toxin concentrations.
• Detection of an early biomarker for disease, toxicity, cell and tissue damage.
• May be used on existing biopsy material.